P ibarot and Dumesnil recently described a state of severe aortic stenosis (AS) with less-than-expected transvalvular gradients (ie, <40 mm Hg), despite preserved ejection fraction, (EF) and termed this condition paradoxical low flow (LF) low gradient (LG) AS. 1,2 They reported that such patients would have more pronounced left ventricular (LV) concentric remodeling, smaller LV cavity size, lower EF, although remaining within the normal range, and more interstitial fibrosis. 3 They hypothesized that LF/LG AS would represent a more advanced state of valvular and ventricular disease in which the ventricle would be failing because of increased afterload and hypertrophy. 3 However, LF/LG AS could also result from confounding situations, such as small body size, 4,5 measurement errors of indexed stroke volume (SVI), transvalvular flow and effective aortic area (EOA) by transthoracic echocardiography (TTE) because of underestimation of LV outflow tract (LVOT) diameter, and finally from discrepancies because of the inherent inconsistencies in the guidelines criteria.
of LV mass, volumes, and EF and of LV hypertrophy and remodeling patterns in AS compared with 2-dimensional TTE. 8 Finally, it can also detect focal fibrosis in AS, [9] [10] [11] with good correlation versus histology and prognosis. 11, 12 Hence, we studied 128 consecutive patients with severe AS defined as EOA <0.6 cm 2 /m 2 and EF >50% using cine, phasecontrast, and contrast-enhanced CMR to: (1) to evaluate the accuracy of AS classification by TTE by comparing measurement of EOA and of LVOT area by TTE against CMR planimetry and of aortic SVI by TTE against phase-contrast CMR; and (2) explore the pathophysiology of different types of AS by comparing LV hypertrophy, remodeling pattern, and focal fibrosis by CMR among high gradient (HG), LG, normal flow (NF), and LF AS with preserved EF.
Methods

Study Population and Design
Consecutive patients with severe AS defined as EOA <0.6 cm 2 /m 2 measured by continuity equation TTE referred for surgery in our valve center between December 2008 and July 2012 were eligible for inclusion into the study. Exclusion criteria were EF <50%, previous myocardial infarction, atrial fibrillation, more than mild concomitant mitral or aortic regurgitation, contraindications to CMR (ferrometallic cerebral aneurysm clips, pacemaker or implantable defibrillator, or severe claustrophobia), and renal insufficiency (glomerular filtration rate <30 mL/min per 1.73 m 2 ), contraindicating injection of gadolinium-based contrast agent. A total of 259 consecutive patients with AS were considered for inclusion into this study. The final study group consisted of 128 patients (Figure 1 ). Severity of AS was confirmed in 119 (93%) patients by transoesophageal echocardiography and in 111 (87%) patients by surgical inspection during open-chest valve replacement. Patients were compared against a control group of 20 healthy asymptomatic subjects >65 years of age, recruited among hospital volunteers, all without history of cardiac disease, with normal echocardiogram, normal rest and exercise ECG, and no significant coronary stenosis on cardiac computed tomography. After giving informed consent to participate in this study, which had undergone approval of the institutional review board of our institution, patients and volunteers underwent CMR and TTE in random order on the same day.
Cardiac MRI
CMR was performed on a 1.5-T system (Intera CV; Philips Medical Systems, Best, the Netherlands) as previously described. 13 Briefly, 10 to 12 consecutive short-axis images and 1 each of 2-, 3-, and 4-chamber long-axis images of the LV were acquired using a cine steady-state free precession sequence to assess myocardial function and mass. Ten to 15 minutes after injection of 0.2 mmol/kg gadolinium-based contrast, identical prescriptions of short-and long-axis slices were acquired using 2-dimensional or 3-dimensional inversion recovery sequences to evaluate focal myocardial fibrosis. To measure AVA and LVOT area, 6 to 8 contiguous cross-sectional cine images of the aortic valve were prescribed starting in the outflow tract and ending at the valve tips and using a 3-cavity view and an oblique coronal view of the aortic outflow tract of the LV as localizers. Finally, phasecontrast images were acquired in a short-axis plane positioned in the LVOT just below the aortic annulus corresponding to LVOT location by TTE. Images were acquired using a cine gradient-echo segmented pulse sequence with retrospective ECG gating and through-plane velocity encoding of 2.5 m/s.
Transthoracic Echocardiography
A standardized complete 2-dimensional Doppler TTE examination was performed according to established guidelines using an IE33 echocardiography system (Philips Medical Systems, Andover, MA) equipped with a 3.5/1.75-MHz phased-array transducer. LVOT diameter was measured in a zoomed cine loop of the parasternal long-axis view in midsystole, parallel and immediately adjacent to the point of insertion of the aortic valve cusps. Pulsed Doppler LVOT velocity was recorded from the apical 5-chamber view in the LVOT, proximal to the aortic valve. Care was taken to optimize the alignment of the ultrasound beam with the blood flow and to avoid sampling in the transvalvular jet or the proximal flow convergence region. Multiple acquisitions of continuous-wave Doppler imaging were obtained from several acoustic windows (5-chamber, right parasternal, and suprasternal view), and the largest aortic jet velocity was used for calculation of EOA.
Coronary Angiography
Coronary angiography was performed using standard Seldinger techniques with multiple selective contrast injections in the right and left coronary artery system. Severity of coronary artery disease was evaluated using Bypass Angioplasty Revascularization Investigation (BARI) score. 14
Data Analysis
TTE images were transferred to dedicated workstations for analysis (Xcelera 1.2 LF4; Philips Medical Systems). Analysis was performed according to standardized guidelines by an experienced physician (S.P.) blinded to clinical and CMR data. EOA was computed using continuity equation, LV volumes and EF using biplane Simpson method, and LV mass using the Devereux formula. Using established parameters for the assessment of AS severity (ie, LF defined as an indexed LVSVI ≤35 mL/m 2 and LG defined as a mean transaortic pressure gradient ≤40 mm Hg), patients were characterized by TTE and divided into 4 groups as previously described: 2 group 1, HG/NF; group 2, HG/LF; group 3, LG/NF; and group 4, LG/LF. CMR images were analyzed using the free-of-charge software Segment v1.9 (http://segment.heiberg.se) by 1 observer (G.B.) blinded to TTE data. LV and right ventricular volumes and EF, indexed LV mass (LVMI), wall thickness, 15 and phase-contrast aortic SVI were computed semiautomatically with manual corrections. 16 AVA by CMR was measured by direct planimetry of the smallest opening of the valve tips during maximal opening of the aortic valve in systole. Inflow angle of the valve was measured in a 3-chamber view. Contraction coefficient was computed as EOA-TTE/AVA-CMR. According to Dweck et al, 8 LV remodeling in AS patients was categorized into 6 predefined patterns relative to 95% confidence intervals of LVMI, indexed LV end-diastolic volume (LVEDV), and mass to volume (M/V) index of normal volunteers: (1) normal ventricular structure (ie, normal M/V, normal LVMI, and normal indexed LVEDV); (2) concentric remodeling (increased M/V but normal LVMI); (3) asymmetric remodeling (increased M/V and normal LVMI with asymmetric remodeling); (4) concentric hypertrophy (increased M/V and LVMI); (5) asymmetric hypertrophy (increased M/V and LVMI with asymmetric remodeling); and (6) eccentric hypertrophy (increased LVMI, dilated indexed LVEDV, normal M/V, and normal EF). Focal fibrosis on delayed enhancement CMR was quantified with a fully automated method, 16 and the results were expressed as percentage of myocardial mass.
Statistical Methods
Statistical analyses were performed using SPSS version 15 (SPSS Corp, Somers, NY) software. Continuous variables were expressed as mean±1 SD and medians (quartiles) when non-normally distributed, and categorical variables as counts and percentages. Categorical variables of patients in different groups were compared using χ 2 or exact test. Continuous variables were compared among groups using ANOVA when normally distributed or else using Kruskall-Wallis test. Individual differences among groups were compared post hoc using Mann-Whitney U tests (with Bonferroni correction for multiple comparisons) for non-normally distributed data, Tukey-Kramers test for normally distributed data with equal variances, and Games-Howell test for normally distributed data with unequal variances. Comparisons were performed crosswise among all 5 groups. Correlation between CMR and TTE data was evaluated by linear regression. Agreement between the 2 methods was assessed by Bland-Altman analysis. All tests were 2-sided, and P<0.05 was considered statistically significant. Table 1 shows baseline clinical characteristics of the study population. Of the 128 patients with severe AS and EF >50%, 69 (54%) had HG/NF, 28 (22%) had HG/LF, 17 (13%) had LG/ NF, and 14 (11%) had LG/LF. Age, sex, symptoms, risk factors, and comorbidity and severity of coronary artery disease were not significantly different among 4 groups of patients. Volunteers were of similar age and body size as patients, but by design, they were asymptomatic and free of diabetes mellitus and coronary artery disease. Also, they had less hypertension.
Results
Study Population
Parameters of AS Severity Among Groups of Patients With AS by TTE and CMR
Parameters of AS severity by TTE are shown in Table 1 , whereas CMR parameters are shown in Table 2 . Typical examples of patients are shown in Figure 2 . By TTE continuity equation, EOA, EOA index, and energy loss index (ELI) were significantly higher in the 2 groups of LG than in the 2 groups of HG AS. Also, valvular resistance was higher in HG AS than in LG AS. In contrast, the valvular aortic impedance was higher in HG/LF and LG/LF AS.
By TTE, there were slight differences in LVOT diameter among groups. Patients with HG/LF AS had slightly lower LVOT. LVOT diameter measured in patients with LG/NF and LG/LF AS was similar. Estimated LVOT area by TTE correlated well with planimetry of LVOT area by CMR (r=0.70; P<0.001); however, planimetry of LVOT area by CMR was systematically greater by ≈30% than estimated LVOT area by TTE, and CMR LVOT shape was always eccentric, with a minimal to maximal diameter ratio of 1:3. However, the amount of underestimation of TTE to planimetric CMR LVOT and the eccentricity of LVOT did not differ significantly among different AS groups. Also, valve inflow angle was similar among groups. LVOT velocity time integral was significantly larger in HG/NF and lower in LG/LF than in the other groups of patients with AS. Transvalvular aortic velocity time integral was significantly greater in HG/NF and HG/LF AS than in LG/NF and LG/LF AS. MRI phase-contrast measurements of SVI correlated significantly with SVI by TTE (r=0.61; P<0.0001), with good agreement between the 2 techniques (mean difference, 1.35 mL/ m 2 ; 95% limits of agreement, −10.6 to 13.3). By CMR, phasecontrast SVI in the LVOT was systematically slightly lower than the difference between indexed LVEDV and indexed LV end-systolic volume from Simpsons method, likely indicating a small amount of mitral regurgitation. CMR phase-contrast SVI measurements confirmed that patients with HG/LF and LG/LF AS had lower aortic SVI compared with HG/NF AS. Also, the differences in phase-contrast SVI between LG/LF and HG/LF and normal volunteers were not statistically significant.
Planimetric AVA by MRI correlated significantly with EOA measured by TTE (r=0.65; P<0.0001; Figure 3A ). Bland-Altman analysis demonstrated that AVA by CMR was systematically larger than continuity equation EOA by TTE (mean difference, 0.16 cm 2 ; 95% confidence interval, 0.0-0.31; Figure 3B ), regardless of the magnitude of EOA. CMR planimetry confirmed significantly higher AVA and indexed AVA for LG/NF AS than for other groups and significantly lower AVA in HG/LF AS than in HG/NF and LG/LF AS (Table 2; Figure 4 Table 2 shows CMR-derived LV and right ventricular EF, volumes, mass, and fibrosis. LVEF by CMR was >50% in all patient groups. There was no difference in LV and right ventricular EF among different groups of patients with AS, but right ventricular and LV EF was higher in HG/NF AS than in controls. Also, indexed LVEDV and indexed LV end-systolic volume did not differ among the different groups of AS and between AS patients and controls. LVMI was significantly higher in patients with AS versus controls. It was highest in patients with HG/LF AS and significantly lower in LG/LF AS than in HG AS ( Figure 5 ). Also, average regional wall thickness was greater in all patients with AS than in controls and was significantly higher in HG/LF AS and lower in LG/LF AS. Mass/volume ratio was significantly higher in all AS patients than in volunteers but did not differ among different types of AS. Remodeling patterns in different types of AS are shown in Table 3 . The type of remodeling was predominantly concentric hypertrophy and did not differ among groups of AS. The amount of myocardial fibrosis measured by CMR averaged 1.5±3.4% but did not significantly differ between the 4 groups of patients (Table 2 ) and was also not significantly higher than that of controls.
LV Hypertrophy, Fibrosis, and Remodeling by CMR in Patients With Different Types of AS
Finally, when patients were separated into only 2 groups (HG and LG AS; Table 4 ), patients with HG AS had significantly lower EOA, ELI, indexed AVA, yet higher LVMI, mass/ volume index, wall thickness, and similar focal fibrosis compared with LG AS.
Discussion
Our study used CMR to evaluate patients with severe AS, classified according to the new proposed TTE AS grading system that stratifies patients by flow and gradient patterns. Our study findings can be summarized as follows:
1. CMR confirmed that classification of AS patterns by TTE was overall accurate. We observed a good correlation between measurements of LVOT, stroke volume, and aortic valve area between TTE and CMR. 2. Patients with paradoxical LG/LF and LG/NF AS had less severe AS severity, less hypertrophy and remodeling, and a similar amount of focal fibrosis compared with HG AS. 20±3 I  22±3  18±3 I  19±3 I   Ao VTI, cm  119±16 III,IV,C  112±16 III,IV,C  89±11 I,II,IV,C  70±10 I,II,III,C  29±4 I- 
Pathophysiology and Underlying Mechanisms of LG AS
Several hypotheses have been advanced to explain discordance of gradients and aortic valve area in severe AS. First, it is important to evaluate the possibility of measurement errors. Both the computation of EOA in the continuity equation and the evaluation of LV stroke volume by TTE hinge on the accurate assessment of the LVOT area obtained from single-plane measurements of LVOT diameter. Because this parameter is squared, small measurement errors of LVOT may cause substantial miscalculations of SVI and EOA. Furthermore, the formula assumes a circular shape for LVOT. However, this was questioned by recent 3-dimensional evaluations of LVOT dimensions by both computed tomography and CMR. [17] [18] [19] In our study, we evaluated whether measurement errors, and in particular underestimation of LVOT diameter or deviation from circular shape, might explain underestimation of both EOA and SVI and thus imitate a false state of LF/LG AS. We observed a relatively good correlation between LVOT area estimates by TTE and direct planimetry by CMR. As previously reported, we also found that the estimated LVOT area by TTE systematically underestimated the true LVOT area as planimetred by CMR because of significant deviation from circular shape. Still, we observed good correlation between estimates of EOA by TTE and planimetric measurements of AVA by CMR, and, as previously reported, 13, 20 we found that planimetric measurements of AVA by CMR were always systematically higher than EOA estimates from the continuity equation TTE. This likely occurs because planimetry and the continuity equation measure different aortic valve orifices; that is, planimetry measures the anatomic orifice, whereas the continuity equation assesses the effective orifice area, which is always smaller than the actual anatomic orifice. It could also result from underestimation of LVOT due to deviation from circular shape. [17] [18] [19] We also observed good correlations between SVI estimates by TTE and CMR. Most important, in our study, there were no differences in the degree of underestimation and of deviation from circular shape of LVOT between different AS groups. Thus, in our study, we confirm that overall classification of AS by TTE was accurate, and that measurement errors likely did not play an important role to explain the phenomenon of LG AS. Inflow shape and valve rigidity 21 may also be other important parameters in EOA estimation by continuity equation. In flexible and funnel-shaped valves, EOA is more flow dependent than in rigid valves. Although in our study, all valves were calcified with similarly flat inflow shape, contraction coefficient was significantly lower in HG/LF AS than in LG/LF AS. This could suggest that HG/LF valves are more rigid and more severely stenotic than LG/LF AS. Another potential source of error is that Doppler TTE may overestimate net transvalvular gradients because of pressure recovery. To correct for this problem, the concept of ELI was introduced. 22 In our study, differences in ELI tallied differences in indexed EOA, indicating that pressure recovery likely did not significantly differ among groups. Pibarot and Dumesnil 3 suggested that more severe concentric LV remodeling might underlie the pathogenesis of LG/LF AS. In their works 1 using TTE, patients with LF AS had more concentric remodeling by presenting smaller cavity size for similar wall thickness and thus greater relative wall thickness ratio compared with NF patients. CMR has significantly better accuracy and reproducibility of measurements of LV thickness, LV volumes, and LV mass compared with estimates performed using M-mode imaging and Teichholz or Devereux formulas. 23, 24 Therefore, it is the technique of choice to evaluate hypertrophy and remodeling patterns in AS. 8 Our findings refute the hypothesis that LG AS presents increased concentric remodeling. On the contrary, we found that indexed mass and wall thickness by CMR were less in LG AS, indicating that remodeling in these patients is reduced rather than increased, and that maladaptive hypertrophy 25 cannot be held responsible to explain LG in AS. It is noteworthy that this absence of significant difference in LV mass in patients with LG AS was also reported by others. 26 Pibarot et al also hypothesized that higher degrees of myocardial fibrosis could result in subtle alterations in LV systolic function, which might be responsible for LG AS. Higher degrees of interstitial fibrosis by biopsy 27 and lower LV strain 26, 27 were reported in patients with LG AS than HG AS. Delayed enhancement CMR is an alternative method to noninvasively detect fibrosis in AS. [9] [10] [11] Although delayed enhancement CMR detects focal replacement fibrosis, which differs from diffuse reactive fibrosis measured by histopathology, 28 significant correlation between both types of fibrosis has been reported. 11 In our present study, using delayed enhancement CMR, we did not find increased amounts of focal fibrosis in patients with LG/LF AS. Also, we did not observe that LG/LF AS has reductions of CMR EF, a precise method for evaluation of systolic function usually well correlated with strain. 29 Another explanation for lower-than-expected gradients in LG AS could be that the guidelines are, per se, inherently inconsistent. Minners et al 4 emphasized that based on the Gorlin equation, for normal cardiac output, an AVA of 1.0 cm 2 should yield a gradient of 26 mm Hg and that a gradient 40 mm Hg would correspond to an AVA of 0.75 cm 2 , suggesting that a proportion of patients with LG do not really have severe AS. In other works, 5 the same authors observed that LF was thus not a necessary prerequisite for inconsistent LG and suggested an adjustment of the AVA cut-off value for severe stenosis to 0.8 cm 2 . They also reported that many patients with LF may, nonetheless, have gradients >40 mm Hg when stenosis severity is high. This was confirmed in our present study, in which 22% of patients had HG/LF. Our study suggests also that the criteria for low flow, that is, SVI ≤35 mL/m 2 , might not, per se, be a sign of abnormality because a large proportion of our normal-aged volunteers had SVI less than this cut-off value. A final hypothesis is that LG AS might be a less severe form of AS than HG AS. This hypothesis is supported by our study because indexed EOA by continuity equation TTE, ELI, and AVA by direct planimetry were less severe in LG than in HG AS. As in other works, ZVA (valvular arterial impedance) was higher in patients with LF than with NF AS. It was hypothesized that this increase in ZVA might indicate higher afterload resulting from reduced systemic arterial compliance, 1 and that this increase in afterload would reduce stroke volume in severe AS. However, in our present study, blood pressure was not higher in patients with LF AS. The limitation of ZVA as a marker of severity of postcharge is clearly the incorporation of SVI in the formula, which may by itself explain the higher value of ZVA in patients with low SVI. Although LV hypertrophy is not necessarily always an adaptive response to AS, 25 our observation of less severe ventricular hypertrophy and wall thickness in patients with LG/LF is also conflicting with the hypothesis that paradoxical LG/LF AS is a more severe form of AS resulting from more severe afterload.
Therefore, although it is not impossible that an admixture of all the previously discussed mechanisms interplay in the pathophysiology of LG AS, the findings of our study contradict the view that LF/LG is a more severe form of AS than HG AS. On the contrary, and in agreement with hemodynamic studies, 5 our data suggest that LFLG is a rather less severe form of AS.
Clinical Implications
The clinical implications of LG and LF AS with preserved EF are still incompletely understood. In particular, their implication on survival remains debated. Some studies reported worse outcome of LF than of NF AS under medical treatment 1, 2, 30, 31 or after valve replacement. 27 In contrast, in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study, 32 outcome of patients with LG severe AS and preserved EF was similar to patients with moderate AS.
Although our study was not a survival study, our data have important clinical implications. The challenge in patients with LG AS is to accurately ascertain AS severity and to identify patients who are most likely to benefit from aortic valve replacement. Our present study outlines that CMR could be a valuable approach for assessing such patients for whom TTE Eccentric hypertrophy 2 (2) 0 (0) 0 (0) 1 (6) 1 (7) All values are n (%). AS indicates aortic stenosis; CMR, cardiac magnetic resonance; and EF, ejection fraction.
results and the clinical findings are discordant, confirming the severity of AS in the presence of lower-than-expected aortic gradients. Also, our study suggests that when such careful evaluation of patients is performed, severity of LG AS appears to be less than that of HG AS.
Limitations
We used stringent selection criteria to exclude patients with conditions that could have influenced LV remodeling. We also excluded patients with atrial fibrillation because variability of stroke volumes and transvalvular gradients might be an important confounder in the accuracy of assessment of AS parameters. Therefore, our conclusions may not apply to all patients with AS, particularly to those with atrial fibrillation. The number of patients with LG and LF AS was small, somewhat limiting the power of our study, yet the overall proportion and absolute number of patients with different types of AS were similar to those reported by others. 26, 31 Because we neither evaluated invasive gradients during cardiac catheterization nor evaluated the severity of calcification by computed tomography, we could not explain all pathophysiological aspects of LG AS and, in particular, we could not measure whether these valves were less calcified and less rigid. In this study, we used delayed gadolinium enhancement (LGE) CMR to assess focal replacement fibrosis. More recently, it was shown that measurement of myocardial extravascular volume fraction 33 by CMR T1 mapping can estimate diffuse interstitial fibrosis. Unfortunately, this technique was not yet available at the time of the study, therefore we could not evaluate diffuse fibrosis in this work. Yet, significant correlation between both types of fibrosis has been reported. 11
Conclusions
We performed comprehensive assessment of patients with severe AS using CMR. Our study demonstrated the accuracy of CMR in evaluating and classifying AS. We also showed that patients with paradoxical LF/LG AS presented less severe AVA and less, rather than more, severe, LV hypertrophy and remodeling and did not have more severe focal fibrosis. This argues against the concept that paradoxical LF/LG AS is a more advanced state of AS than HG AS. Continuous values are mean±SD, and median (Q1-Q3) for non-normal distribution. AS indicates aortic stenosis; AVA, aortic valve area; CMR, cardiac magnetic resonance; EF, ejection fraction; ELI, energy loss index; EOA, effective orifice area; LVMI, indexed left ventricular mass; MS, myocardial segments; M/V, mass/volume ratio; NS, nonsignificant; TTE, transthoracic echocardiography; and WT, wall thickness.
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